대장 검사 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 제품별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Colon Screening Market Growth & Trends:

The global colon screening market size is expected to reach USD 22.21 billion by 2030, registering a CAGR of 4.39% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growing prevalence of colorectal cancer, increasing government initiatives to encourage cancer screening, and ongoing technological advancements in the market are major factors driving the market growth. According to CDC data published in June 2024, the prevalence of IBD in the U.S. is estimated between 2.4 and 3.1 million. Similarly, the worldwide prevalence of ulcerative colitis was expected to be 5 million in 2023.

The development of technologically advanced products in colon screening has significantly contributed to the market's growth. These innovations have enhanced diagnostic accuracy, improved patient comfort, minimized risks associated with traditional procedures, and enabled earlier detection of colon-related diseases, including cancer and polyps. For instance, in May 2024, FUJIFILM launched two innovative endoscopic imaging technologies: CAD EYE and SCALE EYE. CAD EYE is an AI-powered system designed to enhance the detection of colonic mucosal lesions such as polyps and adenomas during colonoscopy.

In addition, the increasing efforts by private and public players worldwide to increase awareness and accessibility of colon screening have further driven the market across different regions. For instance, in November 2024, Guam Regional Medical City introduced an advanced capsule endoscopy service funded by a grant from the USDA Rural Development Program. This innovative, minimally invasive diagnostic solution represents a significant advancement in gastrointestinal healthcare for Guam and the surrounding region, enhancing medical technology while prioritizing patient comfort. Such developments increase access to advanced diagnosis services, thus driving market growth.

Moreover, the widespread adoption of routine screening programs has an effective role in detecting cancers & precancerous polyps. In addition, advancements in colonoscopy technology, including AI-assisted detection, have improved diagnostic efficiency and patient outcomes. For instance, in December 2023, Medtronic expanded its artificial intelligence collaboration with Cosmo Pharmaceuticals, the developer of plug-in software designed to detect health issues during endoscopic examinations automatically.

Key players in the market are engaged in technological advancements, new product launches, and partnerships & collaborations to gain a higher market share. For instance, in February 2022, Medtronic collaborated with the American Society for Gastrointestinal Endoscopy (ASGE) to offer AI-powered colonoscopy technology for colorectal cancer screening in underserved communities of the U.S.

Colon Screening Market Report Highlights:

• Based on type, the test segment held the largest revenue share in the market in 2024. Rising demand for simple and non-invasive screening procedures is propelling the segment growth.
• Based on end use, the hospital segment held the largest revenue share in the market in 2024, owing to the growing number of hospital admissions due to colon cancer and the rise in the adoption of cancer screening.
• North America dominated the global market with a revenue share of 51.3% in 2024 due to the presence of a large number of major market players and the high adoption of advanced technologies.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Regional scope
  • 1.1.3. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Product outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Colon Screening Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising prevalence of colorectal diseases
    • 3.2.1.2. Favorable government initiatives and reimbursement policies
    • 3.2.1.3. Introduction of technologically advanced products
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Stringent regulations
• 3.3. Colon Screening: Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic Landscape
    • 3.3.2.3. Social Landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Legal Landscape
    • 3.3.2.6. Environmental Landscape
• 3.4. Colon Screening Market Number of Procedures, 2018 - 2024
• 3.5. Colon Screening Market Pricing Analysis by Product

Chapter 4. Colon Screening Market Segment Analysis, By Type, 2018 - 2030 (USD Million)

• 4.1. Definition and Scope
• 4.2. Type Market Share Analysis, 2024 & 2030
• 4.3. Segment Dashboard
• 4.4. Global Colon Screening Market, by Type, 2018 to 2030
• 4.5. Test
  • 4.5.1. Test Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.2. Colonoscopy
    • 4.5.2.1. Colonoscopy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.3. Capsule Endoscopy
    • 4.5.3.1. Capsule Endoscopy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.4. Imaging Tests
    • 4.5.4.1. Imaging Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.4.2. Virtual Colonoscopy
      • 4.5.4.2.1. Virtual Colonoscopy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.4.3. Magnetic resonance colonography (MRC)
      • 4.5.4.3.1. Magnetic resonance colonography (MRC) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.5. Others
    • 4.5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.6. End Use, By Test
    • 4.5.6.1. Hospitals
      • 4.5.6.1.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.6.2. Outpatient Facilities
      • 4.5.6.2.1. Outpatient Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Product
  • 4.6.1. Product Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.2. Colonoscopes
    • 4.6.2.1. Colonoscopes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.3. Sigmoidoscopes
    • 4.6.3.1. Sigmoidoscopes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.4. CT Scanners
    • 4.6.4.1. CT Scanners Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.5. Magnetic Resonance Imaging (MRI)
    • 4.6.5.1. Magnetic Resonance Imaging (MRI) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.6. End Use, By Product
    • 4.6.6.1. Hospitals
      • 4.6.6.1.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.6.2. Outpatient Facilities
      • 4.6.6.2.1. Outpatient Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Colon Screening Market Segment Analysis, By Region, 2018 - 2030 (USD Million)

• 5.1. Regional Market Share Analysis, 2024 & 2030
• 5.2. Regional Market Dashboard
• 5.3. Regional Market Snapshot
• 5.4. Colon Screening Market Share by Region, 2024 & 2030:
• 5.5. North America
  • 5.5.1. North America colon screening market, 2018 - 2030 (USD Million)
  • 5.5.2. U.S.
    • 5.5.2.1. Key country dynamics
    • 5.5.2.2. Regulatory framework
    • 5.5.2.3. Competitive scenario
    • 5.5.2.4. U.S. colon screening market, 2018 - 2030 (USD Million)
  • 5.5.3. Canada
    • 5.5.3.1. Key country dynamics
    • 5.5.3.2. Regulatory framework
    • 5.5.3.3. Competitive scenario
    • 5.5.3.4. Canada colon screening market, 2018 - 2030 (USD Million)
  • 5.5.4. Mexico
    • 5.5.4.1. Key country dynamics
    • 5.5.4.2. Regulatory framework
    • 5.5.4.3. Competitive scenario
    • 5.5.4.4. Mexico colon screening market, 2018 - 2030 (USD Million)
• 5.6. Europe
  • 5.6.1. Europe colon screening market, 2018 - 2030 (USD Million)
  • 5.6.2. UK
    • 5.6.2.1. Key country dynamics
    • 5.6.2.2. Regulatory framework
    • 5.6.2.3. Competitive scenario
    • 5.6.2.4. UK colon screening market, 2018 - 2030 (USD Million)
  • 5.6.3. Germany
    • 5.6.3.1. Key country dynamics
    • 5.6.3.2. Regulatory framework
    • 5.6.3.3. Competitive scenario
    • 5.6.3.4. Germany colon screening market, 2018 - 2030 (USD Million)
  • 5.6.4. France
    • 5.6.4.1. Key country dynamics
    • 5.6.4.2. Regulatory framework
    • 5.6.4.3. Competitive scenario
    • 5.6.4.4. France colon screening market, 2018 - 2030 (USD Million)
  • 5.6.5. Italy
    • 5.6.5.1. Key country dynamics
    • 5.6.5.2. Regulatory framework
    • 5.6.5.3. Competitive scenario
    • 5.6.5.4. Italy colon screening market, 2018 - 2030 (USD Million)
  • 5.6.6. Spain
    • 5.6.6.1. Key country dynamics
    • 5.6.6.2. Regulatory framework
    • 5.6.6.3. Competitive scenario
    • 5.6.6.4. Spain colon screening market, 2018 - 2030 (USD Million)
  • 5.6.7. Norway
    • 5.6.7.1. Key country dynamics
    • 5.6.7.2. Regulatory framework
    • 5.6.7.3. Competitive scenario
    • 5.6.7.4. Norway colon screening market, 2018 - 2030 (USD Million)
  • 5.6.8. Sweden
    • 5.6.8.1. Key country dynamics
    • 5.6.8.2. Regulatory framework
    • 5.6.8.3. Competitive scenario
    • 5.6.8.4. Sweden colon screening market, 2018 - 2030 (USD Million)
  • 5.6.9. Denmark
    • 5.6.9.1. Key country dynamics
    • 5.6.9.2. Regulatory framework
    • 5.6.9.3. Competitive scenario
    • 5.6.9.4. Denmark colon screening market, 2018 - 2030 (USD Million)
• 5.7. Asia Pacific
  • 5.7.1. Japan
    • 5.7.1.1. Key country dynamics
    • 5.7.1.2. Regulatory framework
    • 5.7.1.3. Competitive scenario
    • 5.7.1.4. Japan colon screening market, 2018 - 2030 (USD Million)
  • 5.7.2. China
    • 5.7.2.1. Key country dynamics
    • 5.7.2.2. Regulatory framework
    • 5.7.2.3. Competitive scenario
    • 5.7.2.4. China colon screening market, 2018 - 2030 (USD Million)
  • 5.7.3. India
    • 5.7.3.1. Key country dynamics
    • 5.7.3.2. Regulatory framework
    • 5.7.3.3. Competitive scenario
    • 5.7.3.4. India colon screening market, 2018 - 2030 (USD Million)
  • 5.7.4. Australia
    • 5.7.4.1. Key country dynamics
    • 5.7.4.2. Regulatory framework
    • 5.7.4.3. Competitive scenario
    • 5.7.4.4. Australia colon screening market, 2018 - 2030 (USD Million)
  • 5.7.5. South Korea
    • 5.7.5.1. Key country dynamics
    • 5.7.5.2. Regulatory framework
    • 5.7.5.3. Competitive scenario
    • 5.7.5.4. South Korea colon screening market, 2018 - 2030 (USD Million)
  • 5.7.6. Thailand
    • 5.7.6.1. Key country dynamics
    • 5.7.6.2. Regulatory framework
    • 5.7.6.3. Competitive scenario
    • 5.7.6.4. Thailand colon screening market, 2018 - 2030 (USD Million)
• 5.8. Latin America
  • 5.8.1. Brazil
    • 5.8.1.1. Key country dynamics
    • 5.8.1.2. Regulatory framework
    • 5.8.1.3. Competitive scenario
    • 5.8.1.4. Brazil colon screening market, 2018 - 2030 (USD Million)
  • 5.8.2. Argentina
    • 5.8.2.1. Key country dynamics
    • 5.8.2.2. Regulatory framework
    • 5.8.2.3. Competitive scenario
    • 5.8.2.4. Argentina colon screening market, 2018 - 2030 (USD Million)
• 5.9. MEA
  • 5.9.1. South Africa
    • 5.9.1.1. Key country dynamics
    • 5.9.1.2. Regulatory framework
    • 5.9.1.3. Competitive scenario
    • 5.9.1.4. South Africa colon screening market, 2018 - 2030 (USD Million)
  • 5.9.2. Saudi Arabia
    • 5.9.2.1. Key country dynamics
    • 5.9.2.2. Regulatory framework
    • 5.9.2.3. Competitive scenario
    • 5.9.2.4. Saudi Arabia colon screening market, 2018 - 2030 (USD Million)
  • 5.9.3. UAE
    • 5.9.3.1. Key country dynamics
    • 5.9.3.2. Regulatory framework
    • 5.9.3.3. Competitive scenario
    • 5.9.3.4. UAE colon screening market, 2018 - 2030 (USD Million)
  • 5.9.4. Kuwait
    • 5.9.4.1. Key country dynamics
    • 5.9.4.2. Regulatory framework
    • 5.9.4.3. Competitive scenario
    • 5.9.4.4. Kuwait colon screening market, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Recent Developments & Impact Analysis, By Key Market Participants
• 6.2. Company Categorization
• 6.3. Company Profiles
  • 6.3.1. Olympus Corporation
    • 6.3.1.1. Company overview
    • 6.3.1.2. Financial performance
    • 6.3.1.3. Platform benchmarking
    • 6.3.1.4. Strategic initiatives
  • 6.3.2. PENTAX Medical (Hoya Corporation)
    • 6.3.2.1. Company overview
    • 6.3.2.2. Financial performance
    • 6.3.2.3. Platform benchmarking
    • 6.3.2.4. Strategic initiatives
  • 6.3.3. FUJIFILM Holdings Corporation
    • 6.3.3.1. Company overview
    • 6.3.3.2. Financial performance
    • 6.3.3.3. Platform benchmarking
    • 6.3.3.4. Strategic initiatives
  • 6.3.4. Medtronic
    • 6.3.4.1. Company overview
    • 6.3.4.2. Financial performance
    • 6.3.4.3. Platform benchmarking
    • 6.3.4.4. Strategic initiatives
  • 6.3.5. Ambu A/S
    • 6.3.5.1. Company overview
    • 6.3.5.2. Financial performance
    • 6.3.5.3. Platform benchmarking
    • 6.3.5.4. Strategic initiatives
  • 6.3.6. Baxter (Hillrom & Welch Allyn)
    • 6.3.6.1. Company overview
    • 6.3.6.2. Financial performance
    • 6.3.6.3. Platform benchmarking
    • 6.3.6.4. Strategic initiatives
  • 6.3.7. EndoFresh (Daichuan medical)
    • 6.3.7.1. Company overview
    • 6.3.7.2. Financial performance
    • 6.3.7.3. Platform benchmarking
    • 6.3.7.4. Strategic initiatives
  • 6.3.8. Bracco
    • 6.3.8.1. Company overview
    • 6.3.8.2. Financial performance
    • 6.3.8.3. Platform benchmarking
    • 6.3.8.4. Strategic initiatives
  • 6.3.9. Varay Laborix
    • 6.3.9.1. Company overview
    • 6.3.9.2. Financial performance
    • 6.3.9.3. Platform benchmarking
    • 6.3.9.4. Strategic initiatives